¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"passive transfer test2"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • magnetization transfer technique
    ÀÚ¼ºÈ­Àü´Þ±â¼ú
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • magnetic transfer contrast
    ÀÚ±âÈ­Àü´Þ´ëÁ¶µµ
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
  • resistance transfer factor
    ³»¼ºÀü´ÞÀÎÀÚ
  • tendon transfer
    ÈûÁÙÀüÀÌ(¼ú), °ÇÀüÀÌ(¼ú)
  • zygote intrafallopian transfer
    Á¢ÇÕÀÚÀڱðü³»À̽Ä, Á¢ÇÕüÀڱðü³»Àü´Þ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • direct transfer flap
    Á÷Á¢ÇÇÆÇ
  • electro transfer system
    ÀüÀÚÀü´Þ°è, ÀüÀÚ¿î¹Ýü
  • magnetization transfer effect
    ÀÚ±âÈ­Àü´ÞÈ¿°ú
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • free flap transfer
    À¯¸®ÇÇÆÇÀüÀÌ, À¯¸®ÇÇÆÇÀüÀ̼ú
  • frontalis transfer
    À̸¶±Ù¿Å±è¼ú, ÀüµÎ±ÙÀüÀ̼ú
  • transfer factor
    Àü´ÞÀÎÀÚ
  • transfer forceps
    Àü´ÞÁý°Ô, À̵¿°âÀÚ, Àü´Þ°âÀÚ
  • gene transfer
    À¯ÀüÀÚÀü´Þ
  • heat transfer rate
    ¿­Àü´Þ·ü
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • magnetization transfer imaging
    ÀÚÈ­Àü´Þ¿µ»ó
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
  • magnetization transfer pulse
    ÀÚ±âÈ­Àü´ÞÆÄ
  • magnetization transfer ratio
    ÀÚ±âÈ­Àü´ÞºñÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • passive forced duction test
    °ßÀΰ˻ç
  • passive hemagglutination
    Çǵ¿¼º ÀûÇ÷±¸ÀÀÁý(ù¬ÔÑàõîåúìϹëêó¢).
  • passive hemagglutination
    ¼öµ¿Ç÷±¸ÀÀÁý
  • passive hemagglutination
    Çǵ¿¼º ÀûÇ÷±¸ÀÀÁý(ù¬ÔÑàõîåúìϹëêó¢).
  • passive hemagglutination test
    Çǵ¿¼º ÀûÇ÷±¸ÀÀÁý½ÃÇè
  • passive hyperemia
    ¼öµ¿¼º ÃæÇ÷(¡­àõõöúì).
  • passive immunity
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹).
  • passive immunization
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹).
  • passive mobility test
    ¼º´ë°¡µ¿(¼º)°Ë»ç
  • passive movement
    ¼öµ¿¿îµ¿
  • passive movement
    ¼öµ¿¿îµ¿, Çǵ¿¿îµ¿.
  • passive observer
    ¼öµ¿ °üÂûÀÚ
  • passive resistance
    Çǵ¿ÀúÇ×(ù¬ÔÑî½ù÷).
  • passive sensitization
    ¼öµ¿°¨ÀÛ(áôÔÑÊïíÂ).
  • passive shimming
    ¼öµ¿ º¸Á¤
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • methionyl transfer RNA
    ¸ÞƼ¿À´Ñ Àü´Þ(îîÓ¹) RNA
  • methyl-poor transfer RNA
    °ú(Íû)¸ÞÆ¿ Àü´Þ(îîÓ¹)RNA
  • modulator transfer RNA
    Á¤Á¶ÀÚ(ïÚðàí­) Àü´Þ(îîÓ¹) RNA
  • noncollisional energy transfer
    ºñÃæµ¹(ÞªõúÔÍ)¿¡³ÊÁöÀü´Þ(îîÓ¹)
  • phase transfer
    »óÀüÀÌ(ßÓï®ì¹)
  • phosphate group transfer
    Àλê±â ÀüÀÌ(×òß«Ðñï®ì¹)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • phosphoryl-group transfer
    ÀλêÈ­±â ÀüÀÌ(×òß«ûùÐñï®ì¹)
  • phosphoryl transfer potential
    ÀλêÈ­ ÀüÀÌ ÀüÀ§(×òß«ûùï®ì¹ï³êÈ)
  • plasmid transfer
    Çö󽺹̵å Àü´Þ(îîÓ¹)
  • precursor transfer RNA
    Àü´Þ(îîÓ¹) RNA Àü±¸Ã¼(îñÏÌô÷)
  • pre-transfer RNA
    Àü±¸(îñÏÌ)ÀüÀÌ(ï®ì¹)RNA
  • proton transfer potential
    ¾ç¼ºÀÚ(åÕàõí­) ÀüÀÌ ÀüÀ§(ï®ì¹ï³êÈ)
  • resistance-transfer factor
    ÀúÇ×ÀüÀÌ ÀÎÀÚ(ï®ì¹ì×í­)
  • resonance energy transfer
    °ø¸í(ÍìÙ°) ¿¡³ÊÁö ÀüÀÌ(ï®ì¹)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
pavex passive vascular exercise
PCA para-chloramphetamine; parietal cell antibody; passive cutaneous anaphylaxis; patient care assistant...
PH parathyroid hormone; partial hepatectomy; partial hysterectomy; passive hemagglutination; past histo...
PHA passive hemagglutination [test]; peripheral hyperalimentation; phenylalanine; phytohemagglutinin; ph...
PHA-NSP passive hemagglutination to nonstructural protein
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RPHA Reversed Passive Haemagglutination
RPA Reversed Passive Arthus
RPLA Reversed passive latex agglutination
PA passive avoidance
PAR passive avoidance reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • transfer factor
    Àü´Þ ÀÎÀÚ, ÀüÀÌ ¿äÀÎ
  • transfer RNA
    Àü´Þ RNA
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
passive vasodilation Vasodilation related to increased pressure in lumen of a vessel.
(05 Mar 2000)
reversed passive anaphylaxis An anaphylactic reaction induced in an animal injected with a specific antigen, which will bind to reactive tissue, and then, after a latent period, with serum from another animal previously sensitised to the identical antigen.
Synonym: reversed anaphylaxis.
(05 Mar 2000)
reverse passive haemagglutination If antibodies are bonded to the surface of red blood cells haemagglutination will occur if the appropriate bi or multivalent antigen is added in soluble or microparticulate form. Used as a test for for example Hepatitis B virus in the serum.
(18 Nov 1997)
motion therapy, continuous passive Movement of a body part initiated and maintained by a mechanical or electrical device to restore normal range of motion to joints, muscles, or tendons after surgery, prosthesis implantation, contracture flexion, or long immobilization.
(12 Dec 1998)
continuous passive motion A technique in which a joint, usually the knee, is moved constantly in a mechanical splint to prevent stiffness and to increase the range of motion.
(05 Mar 2000)
specific passive immunity See: acquired immunity.
(05 Mar 2000)
natural passive immunity Immunity conferred by the mother on the foetus or newborn.
(14 Nov 1997)
immunization, passive Transfer of immunity from immunised to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (adoptive transfer).
(12 Dec 1998)
euthanasia, passive The withdrawing or withholding of extraordinary means used to prolong life.
(12 Dec 1998)
adoptive transfer Form of passive immunization where previously sensitised immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (immunotherapy, adoptive).
(12 Dec 1998)
gamete intra-fallopian transfer <gynaecology> Gamete intra-fallopian transfer is a technique that involves combining eggs and sperm outside of the body and immediately placing them into the fallopian tubes to achieve fertilization.
A technique that came into use in the mid-1980's for assisted conception in infertile women with normal fallopian tubes. The protocol consists of hormonal stimulation of the ovaries, followed by laparoscopic follicular aspiration of oocytes, and then the transfer of sperm and oocytes by catheterization into the fallopian tubes.
Acronym: GIFT
(12 Dec 1998)
gel transfer Any lab technique used to transfer substances which had been separated using gel electrophoresis from the gel to a membrane for further processing or analysis. For example: any type of blotting.
(09 Oct 1997)
gene transfer <molecular biology> General tem for the insertion of foreign genes into a cell or organism. Synonymous with transfection.
(18 Nov 1997)
cavernous transfer of portal vein <anatomy, vein> Replacement of the portal vein by a number of collateral channels, a consequence of thrombosis.
(05 Mar 2000)
patient transfer Interfacility or intrahospital transfer of patients. Intrahospital transfer is usually to obtain a specific kind of care and interfacility transfer is usually for economic reasons as well as type of care provided.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á